TY - JOUR
TI - Obstructive uropathy in the transplanted kidney: Definitive management
with percutaneous nephrostomy and prolonged ureteral stenting
AU - Pappas, P
AU - Giannopoulos, A
AU - Stravodimos, KG
AU - Zavos, G and
AU - Alexopoulos, T
AU - Boletis, J
AU - Tzortzis, G
AU - Kostakis, A
JO - Journal of Endourology
PY - 2001
VL - 15
TODO - 7
SP - 719-723
PB - MARY ANN LIEBERT INC PUBL
SN - 0892-7790, 1557-900X
TODO - 10.1089/08927790152596316
TODO - null
TODO - Background and Purpose: Renal transplantation is an effective treatment
for end-stage renal disease. Ureteral stenosis is the most frequent
urologic complication. We report our experience with percutaneous
nephrostomy and antegrade ureteral stenting, which may offer a primary
and definitive alternative to open surgery.
Patients and Methods: Fifteen patients with renal allograft obstructive
uropathy were managed with percutaneous nephrostomy and prolonged
ureteral stenting.
Results: Percutaneous nephrostomies were successfully performed in all
15 kidneys: In 13 patients, antegrade ureteral stenting was attempted,
this being successful in 11 (85%). After prolonged ureteral stenting
(mean duration 15 months), the stent was removed in eight patients, and
six of them (75%) did not have recurrences. During follow-up, urea,
creatinine, sodium, and potassium determinations and ultrasound scans
were performed, and success was confirmed by the decline of creatinine
and reduction in hydronephrosis. No major complication was observed.
Conclusion: Percutaneous nephrostomy and ureteral stenting is a safe and
effective treatment for renal allograft obstructive uropathy. Prolonged
ureteral stenting may offer a definitive treatment with low morbidity.
ER -